Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease.
Grattagliano I, Montezinho LP, Oliveira PJ, Frühbeck G, Gómez-Ambrosi J, Montecucco F, Carbone F, Wieckowski MR, Wang DQ, Portincasa P.
Grattagliano I, et al. Among authors: fruhbeck g.
Biochem Pharmacol. 2019 Feb;160:34-45. doi: 10.1016/j.bcp.2018.11.020. Epub 2018 Nov 30.
Biochem Pharmacol. 2019.
PMID: 30508523
Review.